Find all needed information about Bonesupport Cerament G. Below you can see links where you can find everything you want to know about Bonesupport Cerament G.
https://www.bonesupport.com/en-eu/ceramentg/
BONESUPPORT AB is funding a prospective, multi-centre randomised controlled trial to demonstrate the safety and effectiveness of CERAMENT™G used in conjunction with standard-of-care treatment compared to standard-of-care treatment alone for patients with open fractures of the tibial diaphysis.
https://www.bonesupport.com/en-eu/cerament%e2%84%a2/
CERAMENT is a synthetic bone graft substitute that consists of a powder component: 40% hydroxyapatite (HA), 60% calcium sulfate (CaS), and a liquid component (iohexol in CERAMENT ® BONE VOID FILLER and CERAMENT ® V, and saline in CERAMENT ® G, which are mixed to form an injectable paste . It is used to fill gaps or voids in bone to promote bone healing.
https://www.bonesupport.com/en-eu/cerament-bonevoid-filler/
BONESUPPORT AB is funding a multi-centre randomised controlled trial comparing CERAMENT ™ BONE VOID FILLER to autologous bone in the treatment of tibial plateau fractures, for which enrolment is due to be finished in 2017. BONESUPPORT AB is participating in the Baltic Fracture Competence Center (BFCC) project.
https://www.bonesupport.com/en-eu/pr-0762-01-en-cerament-g-canadian-approval-eu.html
BONESUPPORT is currently conducting the FORTIFY trial to assess CERAMENT G’s ability to improve on the standard-of-care management of patients with open fractures of the tibial diaphysis. The primary endpoints of the trial include the absence of deep infection at the fracture site and the lack of secondary procedures intended to promote fracture union.
https://www.edisongroup.com/publication/good-start-in-the-us-cerament-g-v-growth/23720/
Mar 20, 2019 · Bonesupport is an orthobiologics company that has commercialised three synthetic bone graft substitutes and has several other projects in R&D. The marketed products, CERAMENT BVF, CERAMENT G (gentamicin) and CERAMENT V (vancomycin), are intended to help orthopaedic surgeons manage bone voids and defects after injuries or diseases affecting bones.
https://ryortho.com/breaking/cerament-g-effective-in-osteomyelitis/
BONESUPPORT AB is announcing the publication of results from the first 100 patients in a study on CERAMENT G in patients with chronic osteomyelitis using a single stage surgical procedure. The prospective study, published in The Bone and Joint Journal, evaluated CERAMENT G for dead space management in these patients.
Need to find Bonesupport Cerament G information?
To find needed information please read the text beloow. If you need to know more you can click on the links to visit sites with more detailed data.
